ENDONOVO THERAPEUTICS, INC. Diluted Shares Outstanding (Weighted Average)
ENDONOVO THERAPEUTICS, INC. (ENDV) reported Diluted Shares Outstanding (Weighted Average) of 1.35 billion shares for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-12-29.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2023-12-29
- ENDONOVO THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2023-09-30 was 1.35B shares, a 779.43% increase year-over-year.
- ENDONOVO THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2023-06-30 was 1.35B shares, a 905.31% increase year-over-year.
- ENDONOVO THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2023-03-31 was 1.74B shares, a 2106.33% increase year-over-year.
- ENDONOVO THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2022-09-30 was 153.60M shares, a 131.70% increase year-over-year.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month |
|---|---|---|---|
| 2023-09-30 | 1.35B shares 10-Q · filed 2023-12-29 | 1.35B shares derived: average of 2 quarters · filed 2023-12-29 | 1.35B shares 10-Q · filed 2023-12-29 |
| 2023-06-30 | 1.35B shares 10-Q · filed 2023-08-21 | 1.34B shares 10-Q · filed 2023-08-21 | |
| 2023-03-31 | 1.74B shares 10-Q · filed 2023-05-22 | ||
| 2022-09-30 | 153.60M shares 10-Q · filed 2023-12-29 | 143.98M shares derived: average of 2 quarters · filed 2023-12-29 | 122.54M shares 10-Q · filed 2023-12-29 |
| 2022-06-30 | 134.36M shares 10-Q · filed 2023-08-21 | 106.70M shares 10-Q · filed 2023-08-21 | |
| 2022-03-31 | 79.01M shares 10-Q · filed 2023-05-22 | ||
| 2021-09-30 | 66.29M shares 10-Q · filed 2021-11-19 | 62.39M shares derived: average of 2 quarters · filed 2022-08-22 | 55.30M shares 10-Q · filed 2021-11-19 |
| 2021-06-30 | 58.49M shares 10-Q · filed 2022-08-22 | 50.08M shares 10-Q · filed 2022-08-22 | |
| 2021-03-31 | 41.57M shares 10-Q · filed 2021-05-24 | ||
| 2020-09-30 | 16.14M shares 10-Q · filed 2021-11-19 | 12.99M shares derived: average of 2 quarters · filed 2021-11-19 | 23.58M shares 10-Q · filed 2021-11-19 |
| 2020-06-30 | 9.83M shares 10-Q · filed 2021-08-23 | 15.07M shares 10-Q · filed 2021-08-23 | |
| 2020-03-31 | 11.93M shares 10-Q · filed 2021-05-24 | ||
| 2019-09-30 | 777.25K shares 10-Q · filed 2020-11-19 | 677.37K shares derived: average of 2 quarters · filed 2020-11-19 | 613.27K shares 10-Q · filed 2020-11-19 |
| 2019-06-30 | 577.49K shares 10-Q · filed 2020-08-19 | 529.92K shares 10-Q · filed 2020-08-19 | |
| 2019-03-31 | 481.83K shares 10-Q · filed 2020-06-12 | ||
| 2018-06-30 | 347.94M shares 10-Q · filed 2018-08-13 | 337.78M shares 10-Q · filed 2018-08-13 | |
| 2017-06-30 | 330.80M shares 10-Q · filed 2018-08-13 | 198.40M shares 10-Q · filed 2018-08-13 | |
| 2016-06-30 | 111.76M shares 10-Q · filed 2017-08-10 | 108.86M shares 10-Q · filed 2017-08-10 |